Antonino Amato

Antonino Amato got a degree in Medicine at the School of Medicine of the Università Cattolica del Sacro Cuore in Rome and attended a residency program in General Surgery at the Tor Vergata University School of Medicine in Rome.

He is CEO/CMO and board member of BetaGlue Technologies SpA.

Previously he held various managerial positions in the biotech and pharma industry, as founder and Executive Director of the Clinical Trial Center of Fondazione Policlinico Universitario A. Gemelli IRCCS (Rome), General Manager and Chief Executive Officer of Sigma-Tau Research Inc. and then Corporate Director, Product Development at the global level for Sigma Tau.